ETHealthworld.com brings latest marion biotech news, views and updates from all top sources for the Indian Health industry.

The source of this renewed optimism lies in concrete figures related to the U.S. launch of the oral Wegovy variant in January 2026. Market observers believe the daily pill could be a decisive factor ...

Novo Nordisk's Wegovy pill was prescribed more than 18,000 times in the U. in the first full week after its launch in an ...

IF you are a parent and wondering how you can trade bullying, burnout and broken systems for curiosity, confidence and ...

As GLP-1 pills for weight loss enter the U.S. market, some pharmaceutical companies are testing the possibility of a gene therapy to stimulate GLP-1 production, The Washington Post reported Jan. 24.

Eli Lilly and Viking Therapeutics both operate in the high-growth field of obesity drugs. This market is forecast to reach ...

A once-weekly injectable glucose-dependent insulinotropic polypeptide/GLP-1 dual agonist conferred up to 14.7% weight loss at ...

However, not everyone is willing—or able—to indefinitely commit to GLP-1s.

Tia Timmer was always “on the heavier side,” but her weight never held her back – until she had to keep up with two grandchildren.

Insurers cite unsustainable costs as GLP-1 benefits disappear, accelerating a national shift in employer-sponsored ...

Friendly” labels on the packaging are becoming more common in U.S. supermarkets as a growing number of Americans try obesity ...

As 25 pounds slid away, she felt less tired and found herself walking and biking more. Then her Medicare plan notified her it ...